Stemtech (STEK) Research & Development (2023)
Stemtech's (STEK) quarterly Research & Development came in at $177.0 in Q2 2023, down 98.72% quarter-over-quarter from $13800.0 in Q1 2023.
Stemtech (STEK) Research & Development (2023) Analysis & Trends
Stemtech has disclosed Research & Development across 1 years of filings, most recently posting $177.0 for Q2 2023.
- Research & Development for Q2 2023 came in at $177.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $177.0 (down 98.72% YoY), and the FY2023 annual result was $13800.0, changed N/A from the prior year.
- Research & Development came in at $177.0 for Q2 2023 at Stemtech, down from $13800.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $13800.0 in Q1 2023 to a low of $177.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Stemtech | - | - | 354,677.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 177.00 |
| Mar 31, 2023 | 13,800.00 |